LivaNova PLC (LIVN) intrinsic value & 10-year financials

LivaNova PLC (LIVN) has a Graham intrinsic value of $16.75 per share. At $77.58 on Oct 17, 2026, the stock trades 363% above that value. Over the last 10 fiscal years revenue grew 4.1% a year to $1.4B, with an average return on invested capital of -2.0%.

Graham intrinsic value
$16.75
Share price (Oct 17, 2026)
$77.58
Price vs Graham value
363% above
Market cap
$4.2B
Revenue (FY2025)
$1.4B
Revenue growth (10-yr CAGR)
4.1%
ROIC (10-yr avg)
-2.0%
Free cash flow (FY2025)
$173.3M

LIVN 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $1.4B -$242.5M -$4.45 $173.3M 14.4% 15.7%
FY2024 $1.3B $63.2M $1.16 $135.9M 10.3% 5.8%
FY2023 $1.2B $17.5M $0.32 $39.9M -5.9% -2.1%
FY2022 $1.0B -$86.2M -$1.61 $43.4M -7.5% -5.3%
FY2021 $1.0B -$135.8M -$2.68 $77.1M -0.1% -0.1%
FY2020 $934.2M -$345.0M -$7.10 -$114.4M -28.9% -16.5%
FY2019 $1.1B -$155.2M -$3.21 -$115.8M -15.6% -8.5%
FY2018 $1.1B -$189.4M -$3.91 $82.5M -22.4% -10.6%
FY2017 $1.0B -$25.1M -$0.52 $57.2M 9.5% 2.7%
FY2016 $964.9M -$62.8M -$1.29 $53.7M -2.9% -1.6%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

LivaNova PLC has demonstrated mature, steady growth, with revenue compounding at 4.1% annually over the past decade.

LivaNova PLC has historically struggled to out-earn its cost of capital, averaging just -2.1% ROIC.

LivaNova PLC has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, LivaNova PLC is modeled at 4.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $16.75 per share.

LIVN stock: frequently asked questions

What is the intrinsic value of LivaNova PLC (LIVN) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 4.1% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, LIVN's intrinsic value is about $16.75 per share.

Is LIVN stock undervalued?

At $77.58 (close on Oct 17, 2026), LIVN trades 363% above its Graham value of $16.75. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has LivaNova PLC grown?

Revenue went from $964.9M in fiscal 2016 to $1.4B in fiscal 2025, a compound annual growth rate of 4.1%. Net income was -$242.5M in fiscal 2025.

Does LivaNova PLC generate free cash flow?

LivaNova PLC generated $173.3M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 8 of the last 10 reported years.

What is LIVN's return on invested capital?

Average ROIC over the last 10 fiscal years was -2.0%, and average return on equity was -8.6%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this LIVN data come from?

From LivaNova PLC's annual 10-K filings on SEC EDGAR, most recently filed Aug 5, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar electromedical & electrotherapeutic apparatus stocks